This is the authors' abstract. We don't add key points for this paper.
Near-infrared (NIR) light offers significant potential for next-generation nanotherapeutics due to its deep tissue penetration and minimal damage to healthy tissues. Herein, a NIR photoactivated chemical platform for anticancer therapy is proposed, based on the co-encapsulation of a NIR photosensitizer (NIR–PS) and a photoacid generator (PAG) within drug-loaded, acid-degradable poly(ethylene glycol)- b -polyacetal diblock copolymer micelles. These nanocarriers were efficiently internalized by HeLa cells and, upon 808 nm NIR irradiation, underwent degradation that trigger a cascade of processes leading to multimodal cell death. Specifically, activation of the PAG by the NIR–PS via photoinduced electron transfer (PET) generates acid within the micellar cores, inducing the acid-catalyzed main chain degradation of the polyacetal blocks and subsequent drug release. Simultaneously, the irradiated NIR–PS produces reactive oxygen species (ROS), exerting additional cytotoxic effects. Moreover, the intracellular pH imbalance caused by PAG activation further enhanced cell death. These “triple-action” micelles, co-loaded with the NIR–PS, PAG, and the anticancer drug camptothecin, exhibit pronounced cytotoxicity (>88 %) upon NIR irradiation, demonstrating a strong synergistic effect of chemotherapy, photodynamic therapy, and acid-induced cell death. Collectively, these findings validate the in vitro efficacy of the developed platform as a promising system for anticancer therapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ψαρρού et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: